NASDAQ:XAIR Beyond Air (XAIR) Stock Price, News & Analysis $0.44 -0.02 (-5.08%) (As of 10:51 AM ET) Add Compare Share Share Today's Range$0.44▼$0.4650-Day Range$0.38▼$1.3452-Week Range$0.36▼$3.35Volume266,924 shsAverage Volume528,830 shsMarket Capitalization$20.15 millionP/E RatioN/ADividend YieldN/APrice Target$3.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Beyond Air alerts: Email Address Beyond Air MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside735.2% Upside$3.67 Price TargetShort InterestHealthy1.77% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.85Based on 15 Articles This WeekInsider TradingAcquiring Shares$54,706 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.01) to ($0.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.71 out of 5 starsMedical Sector56th out of 924 stocksSurgical & Medical Instruments Industry12th out of 97 stocks 3.5 Analyst's Opinion Consensus RatingBeyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBeyond Air has only been the subject of 4 research reports in the past 90 days.Read more about Beyond Air's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.77% of the outstanding shares of Beyond Air have been sold short.Short Interest Ratio / Days to CoverBeyond Air has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Beyond Air has recently decreased by 23.57%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldBeyond Air does not currently pay a dividend.Dividend GrowthBeyond Air does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBeyond Air has received a 41.63% net impact score from Upright. Beyond Air seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Creating knowledge". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Medical ventilators", "Clinical research services for the respiratory system", and "Preclinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for Beyond Air is -0.91. Previous Next 3.8 News and Social Media Coverage News SentimentBeyond Air has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Beyond Air this week, compared to 1 article on an average week.Search Interest6 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows7 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Beyond Air insiders have bought more of their company's stock than they have sold. Specifically, they have bought $54,706.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders19.00% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.50% of the stock of Beyond Air is held by institutions.Read more about Beyond Air's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Beyond Air are expected to grow in the coming year, from ($1.01) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Beyond Air is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Beyond Air is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyond Air has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Beyond Air's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad TradingTipsBuy these “two-bagger” stocksWe’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today! About Beyond Air Stock (NASDAQ:XAIR)Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.Read More XAIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XAIR Stock News HeadlinesAugust 16, 2024 | insidertrades.comBeyond Air, Inc. (NASDAQ:XAIR) Director Acquires $15,706.40 in StockAugust 22 at 1:25 AM | msn.comBeyond Air files 1.7M secondary stock offeringAugust 22, 2024 | DTI (Ad)3 dividend stocks to ownThe “Income Ace” Jack Carter just revealed his entire dividend strategy. Including 3 specific tickers to consider owning. And his “golden rules” for trading dividend stocks. These aren’t just theoretical rules, either. Jack revealed that the vast majority of his income capital is deployed in this straightforward portfolio of dividend stocks.August 19 at 3:44 AM | americanbankingnews.comRoth Capital Comments on Beyond Air, Inc.'s FY2027 Earnings (NASDAQ:XAIR)August 18, 2024 | americanbankingnews.comBeyond Air (NASDAQ:XAIR) Upgraded to Strong-Buy at Roth CapitalAugust 17, 2024 | americanbankingnews.comErick Lucera Buys 39,266 Shares of Beyond Air, Inc. (NASDAQ:XAIR) StockAugust 16, 2024 | americanbankingnews.comBeyond Air, Inc. (NASDAQ:XAIR) CEO Steven A. Lisi Acquires 100,000 SharesAugust 16, 2024 | americanbankingnews.comRoth Mkm Reaffirms "Buy" Rating for Beyond Air (NASDAQ:XAIR)August 22, 2024 | DTI (Ad)3 dividend stocks to ownThe “Income Ace” Jack Carter just revealed his entire dividend strategy. Including 3 specific tickers to consider owning. And his “golden rules” for trading dividend stocks. These aren’t just theoretical rules, either. Jack revealed that the vast majority of his income capital is deployed in this straightforward portfolio of dividend stocks.August 16, 2024 | americanbankingnews.comBeyond Air, Inc. (NASDAQ:XAIR) Short Interest Down 23.6% in JulyAugust 6, 2024 | investorplace.comXAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q1 2025August 6, 2024 | finance.yahoo.comBeyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate UpdateJuly 31, 2024 | uk.investing.comBeyond Air Inc (XAIR)July 31, 2024 | globenewswire.comBeyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral PneumoniaJuly 23, 2024 | globenewswire.comBeyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6July 16, 2024 | globenewswire.comBeyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024June 25, 2024 | investorplace.comWhy Is Beyond Air (XAIR) Stock Down 22% Today?June 24, 2024 | globenewswire.comBeyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateSee More Headlines Receive XAIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2024Today8/22/2024Next Earnings (Estimated)11/11/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:XAIR CUSIPN/A CIK1641631 Webwww.beyondair.net Phone(516) 665-8200FaxN/AEmployees70Year FoundedN/APrice Target and Rating Average Stock Price Target$3.67 High Stock Price Target$8.00 Low Stock Price Target$1.00 Potential Upside/Downside+735.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-60,240,000.00 Net Margins-5,197.76% Pretax Margin-5,547.46% Return on Equity-203.12% Return on Assets-100.44% Debt Debt-to-Equity Ratio0.54 Current Ratio3.80 Quick Ratio3.61 Sales & Book Value Annual Sales$1.78 million Price / Sales11.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book0.59Miscellaneous Outstanding Shares45,901,000Free Float37,180,000Market Cap$20.15 million OptionableOptionable Beta-0.10 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Steven Adam Lisi (Age 53)CEO & Chairman of the Board Comp: $650kMr. Amir Avniel (Age 50)Co-Founder, President, Chief Business Officer & Director Comp: $400kMr. Michael A. Gaul (Age 69)Chief Operating Officer Comp: $350kMr. Douglas Quinton Larson (Age 53)CFO, Principal Financial Officer & Principal Accounting Officer Comp: $274.95kEdward BargerHead of Investor RelationsMs. Kori-Ann TaylorHead of MarketingDr. Andrew R. Colin M.D.Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory BoardDr. Jeff Myers M.D. (Age 59)Ph.D., Chief Medical Officer Mr. Adam NewmanCorporate SecretaryMore ExecutivesKey CompetitorsTELA BioNASDAQ:TELAHyperfineNASDAQ:HYPRMilestone ScientificNYSE:MLSSInspireMDNYSE:NSPRVivani MedicalNASDAQ:VANIView All CompetitorsInsiders & InstitutionsPoint72 Asia Singapore Pte. Ltd.Bought 87,568 shares on 8/15/2024Ownership: 0.191%Steven A LisiBought 100,000 shares on 8/14/2024Total: $39,000.00 ($0.39/share)Erick LuceraBought 39,266 shares on 8/14/2024Total: $15,706.40 ($0.40/share)AIGH Capital Management LLCSold 75,580 shares on 8/7/2024Ownership: 7.928%Wealth Effects LLCSold 152,700 shares on 8/2/2024Ownership: 0.558%View All Insider TransactionsView All Institutional Transactions XAIR Stock Analysis - Frequently Asked Questions How have XAIR shares performed this year? Beyond Air's stock was trading at $1.96 on January 1st, 2024. Since then, XAIR stock has decreased by 77.6% and is now trading at $0.4390. View the best growth stocks for 2024 here. How were Beyond Air's earnings last quarter? Beyond Air, Inc. (NASDAQ:XAIR) issued its earnings results on Tuesday, August, 6th. The company reported ($0.27) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.39) by $0.12. The business earned $0.68 million during the quarter, compared to analyst estimates of $0.72 million. Beyond Air had a negative trailing twelve-month return on equity of 203.12% and a negative net margin of 5,197.76%. Who are Beyond Air's major shareholders? Beyond Air's top institutional shareholders include AIGH Capital Management LLC (7.93%), Wealth Effects LLC (0.56%) and Point72 Asia Singapore Pte. Ltd. (0.19%). Insiders that own company stock include Robert Carey, Steven A Lisi, Amir Avniel, Ron Bentsur, Michael A Gaul, Erick Lucera and Yoori Lee. View institutional ownership trends. How do I buy shares of Beyond Air? Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Beyond Air own? Based on aggregate information from My MarketBeat watchlists, some other companies that Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH) and General Motors (GM). This page (NASDAQ:XAIR) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
